When time is critical, finding the right clinical trial can mean the difference between hope and despair. In this session, Marshall Van Beurden, CTO at myTomorrows, shares how his team built a GenAI-powered platform on Amazon Bedrock that’s transforming this process—turning complex global trial data into life-changing matches with 98% accuracy and 90% faster than before. To date, the platform has assessed 300,000 patients, connected 16,000+ individuals to treatment opportunities, and supports 50+ pharma partners across 128 countries—with fully integrated APIs, enterprise-grade compliance, and patient-first support. This is GenAI with real impact—where advanced tech meets urgent human need. To close, Guy Kfir, AWS GenAI Lead for Benelux, will briefly highlight what’s next with Amazon Bedrock AgentCore and the future of agentic innovation.

When time is critical, finding the right clinical trial can mean the difference between hope and despair. In this session, Marshall Van Beurden, CTO at myTomorrows, shares how his team built a GenAI-powered platform on Amazon Bedrock that’s transforming this process—turning complex global trial data into life-changing matches with 98% accuracy and 90% faster than before. To date, the platform has assessed 300,000 patients, connected 16,000+ individuals to treatment opportunities, and supports 50+ pharma partners across 128 countries—with fully integrated APIs, enterprise-grade compliance, and patient-first support. This is GenAI with real impact—where advanced tech meets urgent human need. To close, Guy Kfir, AWS GenAI Lead for Benelux, will briefly highlight what’s next with Amazon Bedrock AgentCore and the future of agentic innovation.